Cyclica is the partner of choice for data-driven drug discovery.
Cyclica is the partner of choice for data-driven drug discovery. They advance molecules that embrace the complexity of the disease. They decentralize innovation with technology, build novel data-driven pipelines, and fuel cross-organizational collaborations at a molecular level.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 15, 2022 | Grant | $2.40M | 1 |
![]() |
— | Detail |
Jun 24, 2020 | Series B | $23M | 4 |
![]() |
— | Detail |
Jul 1, 2019 | Series Unknown | — | 1 | — | — | Detail |
Jul 26, 2017 | Series A | $2.25M | 4 |
![]() |
— | Detail |
Sep 22, 2016 | Series A | $2.40M | 2 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |
![]() |
Yes | Series B |
![]() |
— | Series B |
![]() |
— | Series B |
![]() |
— | Series B |
![]() |
— | Series A |
![]() |
— | Series A |
|
— | Series A |
|
— | Series A |
![]() |
— | Seed |